CopilotIQ

What CopilotIQ does

CopilotIQ, Inc. is a Nashville-based, Delaware-incorporated healthcare technology company founded in 2021 that operates a remote patient monitoring (RPM) platform for seniors aged 65 and older with type 2 diabetes and/or hypertension. The platform combines proprietary connected devices — including a glucose meter, blood pressure cuff, and digital scale, with compatibility for hardware partner devices from Biotel and Withings — with predictive AI analytics that process physiological data at approximately 1000x the frequency of legacy monitoring methods. Data feeds continuous monitoring, real-time critical alerts, and personalized care plans that are delivered through one-on-one coaching sessions with US-based licensed nurses via phone and video, with telemedicine consultations provided through CopilotIQ Medical, P.A. and affiliated medical groups. The platform integrates with Apple Health, Google Fit, and the athenahealth patient portal, allowing readings to flow into both the member's record and their primary care physician's workflow.

The company's business model is built around Medicare and Medicare Advantage reimbursement for Remote Patient Monitoring services. Members enroll by calling a member services line, where eligibility is verified against their insurance coverage; services are billed directly to insurance payers under CMS RPM CPT codes on a recurring monthly cadence, with patients responsible only for standard copayments, coinsurance, and deductibles. There is no publicly disclosed self-pay pricing. Services are currently available across 11 US states — Alabama, Florida, Georgia, Indiana, Kentucky, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, and Virginia — and distribution combines direct-to-consumer outreach with health plan and provider referral channels.

In October 2024, CopilotIQ announced an all-stock merger with Biofourmis at HLTH 2024, accompanied by a $100 million investment from existing backers General Atlantic and Bessemer Venture Partners. CopilotIQ CEO David Koretz retained leadership of the combined entity, which is positioned as the first end-to-end AI-driven platform for in-home care across the full acuity spectrum, spanning consumer-facing RPM and enterprise health plan and provider relationships. The combined company is reported to be positioning toward public markets. The platform is HIPAA-compliant, BBB-accredited, and TrustedSite-certified, and operates with a headcount in the 251–500 range from its headquarters at 40 Burton Hills Blvd, Suite 200, Nashville, Tennessee.

Name

CopilotIQ

Legal name

CopilotIQ, Inc.

Website

https://copilotiq.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

251–500 employees

Short description

CopilotIQ is a Nashville-based remote patient monitoring company that combines connected devices and predictive AI with US-based licensed nurse coaching to help Medicare seniors manage type 2 diabetes and hypertension across 11 US states.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring

NAICS

Offices of Physicians (6211), Services for the Elderly and Persons with Disabilities (624120)

SIC

Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

akta.pro secondary industries

Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD) (HLACAGAG)

Keywords

• Remote patient monitoring
• Chronic care management
• Telehealth nurse coaching
• Connected health devices
• Medicare RPM services

Headquarters

HQ city

Nashville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Remote Patient Monitoring Services: Revenue is generated through Remote Patient Monitoring (RPM) services billed to Medicare and Medicare Advantage plans. The service includes device provision, data monitoring, and nurse telehealth consultations. Services are covered as part of health insurance benefits, with CopilotIQ billing insurance payers directly. Patients may be responsible for copayments, coinsurance, and deductibles not covered by their plan.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

CopilotIQ delivers a data-driven Remote Patient Monitoring program for U.S. seniors aged 65+ with type 2 diabetes and/or hypertension. Members receive connected medical devices (glucose meter, blood pressure cuff, digital scale) that automatically transmit readings to a proprietary platform with predictive AI analysis. US-based licensed nurses provide one-on-one coaching by phone and video, generate personalized care plans, and coordinate with the member's primary care physician, with services billed to Medicare and most Medicare Advantage plans.

Product overview

CopilotIQ offers a unified remote health monitoring platform for seniors, combining a proprietary technology platform with connected medical devices (glucose meter, blood pressure cuff, digital scale), dedicated US-based nurse coaching services, and telemedicine consultations. The platform uses predictive AI to analyze health data collected at 1000x the rate of traditional methods, enabling real-time alerts and personalized care plans for managing diabetes and hypertension. Services are offered through the web platform and mobile app, with devices provided to members for out-of-the-box use.

Differentiator

Problem solved

Functional benefit

Products and services

• CopilotIQ Remote Health Monitoring Platform A data-driven remote health monitoring platform for seniors aged 65+ that combines connected devices, predictive AI, and US-based licensed nurses to help older Americans manage chronic conditions like type 2 diabetes and hypertension. The service is covered by Medicare and most Medicare Advantage plans.
• Dedicated Nurse Coaching Members are paired with US-based licensed nurses who provide frequent one-on-one coaching sessions by phone and video, helping with diet, exercise, lifestyle, and accountability for seniors managing chronic conditions.
• Telemedicine Consultations Telehealth consultations provided by independent medical practitioners through CopilotIQ Medical, P.A. and affiliated medical groups, including diagnosis, treatment recommendations, and prescription services for enrolled members.

Quantifiable outcome

• 93% patient satisfaction/recommendation rate for patients with type 2 diabetes or hypertension
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability2 records

Feature4 records

Partnerships

One partnership is on record.

• BiofourmisflagshipStrategic or Co-development Partner · 28 October 2024CopilotIQ and Biofourmis announced a strategic merger at HLTH 2024 to create the first end-to-end AI-driven platform for in-home healthcare. The all-stock transaction combines consumer-facing and enterprise capabilities. CopilotIQ CEO David Koretz leads the combined entity. An additional $100M investment from existing investors accompanied the merger.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Biofourmis: Now merged with CopilotIQ as of October 2024, Biofourmis is the closest direct peer — an AI-driven remote monitoring and hospital-at-home platform. The two were combined to create an end-to-end in-home care platform spanning consumer and enterprise markets.
• Vivify Health (Optum): One of the largest US RPM platform providers serving health plans, hospitals, and ACOs with connected devices and care pathways for chronic conditions. Highly comparable product set, with a broader enterprise footprint than CopilotIQ.
• Health Recovery Solutions (HRS): Direct RPM competitor offering connected device kits, telehealth, and care pathways for chronic disease and post-acute care. Targets similar Medicare populations and health-plan partnerships, with broad enterprise customers.
• Omada Health: Digital chronic disease management platform focused on diabetes, hypertension, and pre-diabetes prevention. Overlaps heavily on cardiometabolic care for adults and increasingly seniors, though Omada historically leads with employer/payer contracts rather than DTC Medicare.

Broad incumbents

• Livongo (Teladoc Health): Livongo pioneered connected-device chronic disease management (diabetes, hypertension) for self-insured employers and is now embedded inside Teladoc Health. A direct conceptual competitor on condition coverage and outcome-based pricing, but with much broader enterprise scale.
• Verily (Alphabet): Alphabet's precision health arm building chronic disease, RPM, and care management programs for at-risk populations. Competes with CopilotIQ on AI-driven population health but operates at much broader scale and across more conditions.
• Dexcom: Continuous glucose monitoring market leader widely used in diabetes care. Overlaps with CopilotIQ's glucose-monitoring component but operates as a device/pharma-style platform rather than a service-coaching model.

Others

• Withings: Connected health device manufacturer (blood pressure cuffs, scales, watches) and a CopilotIQ hardware integration partner. Adjacent rather than directly competitive, but its devices form part of the CopilotIQ monitoring ecosystem.

Emerging players

• WellDoc (BlueLoop): Digital health platform providing AI-driven diabetes and cardiometabolic condition management for health plans, employers, and providers. Comparable chronic-condition focus, with payer integrations similar to CopilotIQ's Medicare Advantage channel.
• Hinge Health: Digital MSK and chronic pain platform pairing wearable sensors with remote coaches. Not a direct RPM peer but a comparable digital-health blueprint: connected hardware + AI + human coaching, sold into payers and employers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/copilotiq
• Facebookfacebook.com/copilotiq
• LinkedInlinkedin.com/company/copilotiq

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CopilotIQ